NFKB1 and myeloproliferative disorder: Another mechanism exploited by MPN-MSCs could be an exaggerated activation of the pro-inflammatory NF-kB pathway, leading to cytokine release, and proliferation and maintenance of the mutated HSCs and myeloid and lymphoid precursors (65, 66).